Target intelligence / Profile preview

Rap1 GTPase-GDP dissociation stimulator 1 (RAP1GDS1)

Target
RAP1GDS1
Molecular classification
Enzyme, Guanine nucleotide exchange factor (GEF), Regulatory protein for small GTPases
01

Overview

Rap1 GTPase-GDP dissociation stimulator 1 (RAP1GDS1) is a guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP in members of the small GTPase family, particularly Rho and Ras subfamilies, including Rap1a, Rap1b, RhoA, RhoB, and KRas[8][1][3]. It stimulates the dissociation of GDP, thereby activating these G proteins to regulate diverse cellular processes such as integrin-mediated cell adhesion, cell proliferation, cytoskeletal dynamics, and various signaling networks[1][3][8]. RAP1GDS1 is implicated in cancer cell progression, mitochondrial fission, cytoskeletal remodeling, and other fundamental cellular processes[5][4]. If additional structured data (such as specific drug interactions, biomarker status, or safety profiles for therapeutic modulation) becomes available, those fields should be updated accordingly; current data do not support specific interacting drugs or clinical biomarkers at this time.

Other names
Guanine nucleotide exchange factor SmgGDSSmgGDSGDS1RAP1 GDS1
02

Mechanism of action

Facilitates GDP dissociation and GTP binding on target small GTPases, activating downstream signaling pathways

03

Biological functions

Stimulates GDP/GTP exchange of small GTPase proteins (G proteins)Regulation of integrin-mediated cell adhesionSignal transduction via Rho and Ras GTPase familiesInfluence on cell proliferation and cytoskeleton organization
04

Disease associations

Cancer (tumor progression, cell cycle progression)Other (cellular stress pathways, shown in neurological aging models, and possible viral pathogenesis)
05

Safety considerations

Potential impact on cell proliferation and tumorigenesis if dysregulated

Beyond the preview

Go deeper on Rap1 GTPase-GDP dissociation stimulator 1 (RAP1GDS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rap1 GTPase-GDP dissociation stimulator 1 (RAP1GDS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call